Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of the Prostate Stage II”

383 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 383 results

Testing effectiveness (Phase 2)Study completedNCT00888654
What this trial is testing

Diindolylmethane in Treating Patients With Stage I or Stage II Prostate Cancer Undergoing Radical Prostatectomy

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute 41
Testing effectiveness (Phase 2)Study completedNCT00003614
What this trial is testing

Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Eastern Cooperative Oncology Group
Not applicableEnded earlyNCT00379119
What this trial is testing

Effect of Androgen Blockade Therapy on Thymus Function in Older Patients Who Have Undergone Radical Prostatectomy for Localized Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 20
Testing effectiveness (Phase 2)Study completedNCT00054522
What this trial is testing

Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy

Who this might be right for
Prostate Cancer
Roswell Park Cancer Institute 15
Testing effectiveness (Phase 2)Study completedNCT03693612
What this trial is testing

GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors

Who this might be right for
Neoplasms
GlaxoSmithKline 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT03371719
What this trial is testing

Radiation Therapy With or Without Apalutamide in Treating Patients With Recurrent Prostate Cancer, the BALANCE Trial

Who this might be right for
Recurrent Prostate CarcinomaStage III Prostate Adenocarcinoma AJCC v7Stage IV Prostate Adenocarcinoma AJCC v7
NRG Oncology 324
Large-scale testing (Phase 3)Study completedNCT00062309
What this trial is testing

Comparison of Two Radiation Therapy Regimens in Treating Patients With Stage II or Stage III Prostate Cancer

Who this might be right for
Prostate Cancer
Fox Chase Cancer Center 307
Testing effectiveness (Phase 2)Study completedNCT01468532
What this trial is testing

Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
Barbara Ann Karmanos Cancer Institute 18
Testing effectiveness (Phase 2)Study completedNCT00246753
What this trial is testing

Lapatinib in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Prostate Cancer
UNC Lineberger Comprehensive Cancer Center 29
Testing effectiveness (Phase 2)Study completedNCT00976755
What this trial is testing

Everolimus as First-Line Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Swiss Cancer Institute 37
Not applicableEnded earlyNCT02024685
What this trial is testing

Treatment Decision Analysis Model for Prostate Cancer: A Randomized Trial

Who this might be right for
Adenocarcinoma of ProstateAdenocarcinoma of the Prostate Stage IAdenocarcinoma of the Prostate Stage II+1 more
Case Comprehensive Cancer Center 76
Testing effectiveness (Phase 2)Study completedNCT00499408
What this trial is testing

Vitamin D and Soy Supplements in Treating Patients With Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Wake Forest University Health Sciences 26
Testing effectiveness (Phase 2)Study completedNCT01075308
What this trial is testing

SB939 in Treating Patients With Recurrent or Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
NCIC Clinical Trials Group 32
Testing effectiveness (Phase 2)Study completedNCT00390468
What this trial is testing

Tandutinib in Treating Patients With Progressive Prostate Cancer and Bone Metastases

Who this might be right for
Metastatic CancerPainProstate Cancer
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Study completedNCT00087165
What this trial is testing

GTI-2040, Docetaxel, and Prednisone in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
University Health Network, Toronto 22
Testing effectiveness (Phase 2)WithdrawnNCT00003622
What this trial is testing

Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy

Who this might be right for
Prostate Cancer
James Ahlgren
Testing effectiveness (Phase 2)Study completedNCT00005028
What this trial is testing

Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University of Maryland, Baltimore 46
Early research (Phase 1)Study completedNCT00099086
What this trial is testing

Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Medical University of South Carolina 20
Testing effectiveness (Phase 2)Study completedNCT01026623
What this trial is testing

Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerProstate AdenocarcinomaRecurrent Prostate Carcinoma+1 more
National Cancer Institute (NCI) 16
Testing effectiveness (Phase 2)Ended earlyNCT00483561
What this trial is testing

Gefitinib and Etoposide in Treating Patients With Advanced Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Prostate Cancer
University of Nebraska 26
Load More Results